BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Patient Worthy - ECPv5.12.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Patient Worthy
X-ORIGINAL-URL:https://patientworthy.com
X-WR-CALDESC:Events for Patient Worthy
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200513T183000
DTEND;TZID=America/New_York:20200513T193000
DTSTAMP:20260523T134929
CREATED:20200506T205208Z
LAST-MODIFIED:20200506T205208Z
UID:181922-1589394600-1589398200@patientworthy.com
SUMMARY:Takeda's Alunbrig Web Event
DESCRIPTION:Speakers: Tarek Mekhail\, MD\, Advent Health Cancer Institute & Larissa\, Patient Ambassador\nJoin us to learn more about ALK+ non-small cell lung cancer (NSCLC) and ALUNBRIG (brigatinib) as a treatment option for ALK+ NSCLC. Hear a healthcare professional speak about ALK+ NSCLC and ALUNBRIG (brigatinib). Hear the story and treatment experience of a person living with ALK+ NSCLC.\nTo register for this webinar\, visit ALUNBRIGWebEvents.com\nAcknowledgment: This event post is sponsored by Takeda and is promoted through the Patient Worthy Collaborative Content program. We only publish content that embodies our mission of providing relevant\, vetted and valuable information to the rare disease community.
URL:https://patientworthy.com/event/takedas-alunbrig-web-event-2/
CATEGORIES:ALK+ Non-Small Cell Lung Cancer
END:VEVENT
END:VCALENDAR